Report Highlights
The global market for neurology devices is estimated to increase from $23.7 billion in 2023 to reach $31.7 billion by 2028, at a compound annual growth rate (CAGR) of 6.0% from 2023 through 2028.
Report Includes
- 20 data tables and 18 additional tables
- An overview of the global markets for neurology devices
- In-depth analysis of global market trends, featuring historical revenue data for 2020-2022, estimated figures for 2023, as well as forecasts for 2028. This analysis includes projections of Compound Annual Growth Rates (CAGRs) spanning through 2028
- Evaluation of the current market size and revenue growth prospects specific to neurology devices, accompanied by a comprehensive market share analysis categorized by product type, and geographical region
- Discussion on the emerging technologies in neurology devices market and areas of focus to forecast the market into various segments and sub-segments
- Assessment of the key drivers and constraints that will shape the market for neurology devices and discussion on the upcoming market opportunities
- Detailed description of the competitive landscape, product mapping, major player's strategic initiatives, R&D activities, and other initiatives
- Detailed profiles of leading market participants, including Medtronic, Abbott, Terumo, Boston Scientific Corp., Natus Medical Inc., and Siemens Healthineers
Report Scope
This report is a comprehensive study of the global market for neurology devices. It describes the neurology devices market and segments it by product type and region. Based on product type, the market is segmented into neurosurgical devices, neuromodulation devices, neurovascular devices and neurodiagnostic devices. The market is segmented by region into North America, Latin America, Europe, Asia-Pacific and Rest of the World (RoW).
This report examines the factors driving growth in the neurology devices market, and it reviews major players, established companies, and new entrants.
In this report, the neurosurgical devices segment covers neurosurgical instruments, neurosurgery support devices/equipment, such as surgical microscopes, surgery navigation systems, and in the neurodiagnostic segment CT. MRI scanners are also considered as their role is prominent in the diagnosis of brain tumors and for radiosurgery applications. The revenue estimations are done for CT and MRI scans based on the neurology application point of view rather than the sales of the devices in this segment. The report does not cover neuro diagnostic assays, biomarker assays and related IVD instruments. It is purely focused on clinical applications, not research-oriented ones.
Report Synopsis
| Report Metrics | Details | ||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Base year considered | 2022 | ||||||||||||||||||||
| Forecast period considered | 2023-2028 | ||||||||||||||||||||
| Base year market size | $22.7 billion | ||||||||||||||||||||
| Market size forecast | $31.7 billion | ||||||||||||||||||||
| Growth rate | CAGR of 6.0% for the forecast period of 2023-2028 | ||||||||||||||||||||
| Units considered | $ Millions | ||||||||||||||||||||
| Segments covered | Product, Type, and Geographic Region | ||||||||||||||||||||
| Regions covered | North America, Europe, Asia-Pacific, Latin America, and Rest of the World | ||||||||||||||||||||
| Countries covered | U.S., Canada, Mexico, Brazil, Argentina, Chile, Germany, France, UK, Italy, Spain, China, India, Japan, and Africa | ||||||||||||||||||||
| Key Market Drivers |
|
||||||||||||||||||||
| Companies studied |
|
||||||||||||||||||||
Frequently Asked Questions (FAQs)
Analyst Credentials
Gundreddy Gopinadh– Associate Consultant-Life Sciences Research
Gopinadh is an experienced professional with nearly nine years in the market research industry and experience in research and analysis, specializing in medical devices, pharmaceuticals, biotechnology, and in-vitro diagnostics verticals. He is an expert in handling custom projects by gathering data points, analyzing market trends, and ultimately providing clients with accurate market size numbers, actionable insights, and recommendations based on their unique business needs. Academically, Gopinadh holds a master’s degree in biotechnology from VIT University.
Related Reports
Brain-Computer Interface: Global Markets
The global market for brain computer interface (BCI) was valued at $2.1 billion in 2023. The market is expected to grow from $2.3 billion in 2024 to $4.5 billion by 2029, at a compound annual growth rate (CAGR) of 14.2% from 2024 through 2029.
Neurostimulation: Technologies and Global Markets
The global neurostimulation devices market should reach $11.7 billion by 2028 from $8.2 billion in 2023 at a compound annual growth rate (CAGR) of 7.4% for the forecast period of 2023 to 2028. Whereas the market was $7.7 billion in 2022 (base year).
Epilepsy Monitoring Devices: Global Market Outlook
This report aims to provide a comprehensive study of the global market for epilepsy monitoring devices. Current and historical market revenues can be estimated based on the product type, and end-user type. The report presents analysis of the market data from 2021 (base year), estimates from 2022, projections of CAGRs through 2027.
Neurology Market: A BCC Research Overview
The global market for neurology should grow from $33.3 billion in 2019 to $39.4 billion by 2024 at a compound annual growth rate (CAGR) of 3.5% for the period of 2019-2024.
Recent Reports
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Direct-to-Consumer Genetic Testing: Global Markets and Technologies
The global market for DTC genetic testing is expected to grow from $2.3 billion in 2024 and is projected to reach $3.7 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.0% during the forecast period of 2024 to 2029.
Global Medical Tapes Market
The global market for medical tapes is expected to grow from $5.6 billion in 2024 and is projected to reach $7.0 billion by the end of 2029, at a compound annual growth rate (CAGR) of 4.7% during the forecast period of 2024 to 2029.
Global Prenatal Testing Market
The global market for prenatal testing is expected to grow from $10.9 billion in 2023 and projected to reach $19.8 billion by the end of 2028, at a compound annual growth rate (CAGR) of 12.6% during the forecast period of 2023 to 2028.
Global Skin Allergy Testing Market
The global market for skin allergy testing is expected to grow from $560 million in 2023 to $771.5 million by the end of 2028, at a compound annual growth rate (CAGR) of 6.6% from 2023 to 2028.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More